Qiagen N.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
11 jan 2015 - 18:48
Statutaire naam
Qiagen N.V.
Titel
QIAGEN acquires Enzymatics enzyme solutions unit, a leading enabler of NGS applications
Bericht
QIAGEN acquires Enzymatics enzyme solutions unit, a leading enabler of NGS applications
• Enzymatics products used in 80% of all global NGS sequencing reactions
• Strengthens QIAGEN’s universal NGS product offering and strategy to offer complete NGS workflows from sample to insight
• Adds comprehensive R&D, manufacturing, formulation and analytical capabilities in enzymology
• Strategic partnership formed with ArcherDX, including technology and distribution rights to proprietary Archer NGS panel technology
• QIAGEN reaffirms fourth-quarter and full-year 2014 adjusted net sales guidance; charges to be taken related to acquisition and other restructuring activities
Gerelateerde downloads
Datum laatste update: 27 juli 2024